Cell and gene therapies have a huge curative potential but come with a large price tag that can result in access barriers. At ...
Cell and gene therapies are currently niche products, even within specialty pharmacy, drugs that, by most definitions, are ...
Frederik Huhn and Dr. Katharina Haft discuss how digital non‑contact dispensing is enabling miniaturized, sustainable liquid ...
Researchers use AI to discover 14 distinct nucleosome states, revealing that DNA packaging acts as a "volume dial" for gene ...
Weapons and Power Weapons are your primary tools to use against the horde of enemies you'll fight playing Saros. Each Weapon ...
The company released a photo showing the first Semi coming off a new high volume production line in Nevada on April 29, 2026.
Pliant Therapeutics (Nasdaq: PLRX) today announced the dosing of the first participant in the FORTIFY Phase 1b open-label indication expansion ...
When the FDA announced recently that two drug companies had begun streaming clinical trial data to agency reviewers in real ...
Pliant Therapeutics (Nasdaq: PLRX) today announced the dosing of the first participant in the FORTIFY Phase 1b open-label ...
A new machine learning tool called PhysMAP separates the electrical signatures of different cell types, offering a new way to ...
An analysis of counting-efficiency effects in non-volumetric particle counters explains discrepancies across channels.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results